HAI 2024 – HUMAN AMYLOID IMAGING
January 17-19, 2024, Miami, Florida
The students of Dr. Rosa-Neto attended the 2024 Human Amyloid Imaging (HAI2024) in Miami, Florida on January 17th and 19th. It consisted of a ground-breaking series of talks on fluids and PET- biomarkers used in research on dementia. The conference remains at the forefront of unraveling the mechanisms and improving the diagnosis and understanding of Alzheimer’s and other related neurodegenerative diseases. At this conference, attendees had the opportunity to review the basic, fundamental principles of amyloid and tau, Alzheimer’s Disease hallmarks, and using fluids and PET biomarkers. The students presented their work at the international conference which allowed them to learn and exchange their research in the field with other research groups. MCSA Students that attended include: Nesrine Rahmouni, Yi-Ting Wang, Jaime Arias Fernandez, Ali Hosseini, Lydia Trudel, Brandon Hall, Etienne Aumont and Wan Lu Ji.
AD/PD 2024 – International Conference on Alzheimer’s And Parkinson’s Diseases And Related Neurological Disorders
March 5-9, 2024 – Lisbon, Portugal
The students from the McGill Research Centre for Studies in Aging attended the 2024 Alzheimer’s Disease and Parkinson’s Disease (ADPD2024) conference which consisted of a ground-breaking series of talks on fluids and PET-biomarkers used in research on dementia. The conference remains at the forefront of unraveling the mechanisms and improving the diagnosis and understanding of Alzheimer’s and other related neurodegenerative diseases. This year, the conference was hosted in Lisbon, Portugal, from March 4th to March 9th. At this conference, attendees had the opportunity to review the basic, fundamental principles of amyloid and tau, Alzheimer’s Disease hallmarks, using fluids and PET biomarkers. Attending this conference allowed the students to learn more about neuroimaging and biomarkers, which are the key subjects of their thesis: discussing the pathogenesis of Alzheimer’s Disease, using plasma and PET-imaging biomarkers. They will be presenting their work at this at this international conference which would allow them to learn and exchange about their research in the field with other research groups.
XIV International Symposium on Functional Neuroreceptor Mapping of the Living Brain (NRM2024)
May 18-21, 2024, Montreal, Quebec
The XIV Neuro Receptor Mapping (NRM) Conference took place at the Centre Monty-Royal in Montreal from May 18-21, 2024. First established by Prof. Dr. Albert Gjedde in 1997, this biennial event focuses on the in-vivo quantification of brain function using Positron Emission Tomography (PET). Known for its innovative approach and significant impact, the conference was hosted by McGill University’s CaTS, the Montreal Neurological Institute, and the Douglas Mental Health University Institute. The following provides an overview of the events and key details from the 4-day conference. The NRM community is responsible for significant progress in detection of brain neurodegenerative conditions such as Alzheimer’s disease.
AAIC 2024 – The Alzheimer Association International Conference
July 28- Aug 1, 2024 – Philadelphia, U.S.A
The students from the McGill Research Centre for Studies in Aging attended the 2024 Alzheimer’s Association International Conference (AAIC2024) which consists of a ground-breaking series of talks on fluids and PET-biomarkers used in research on dementia. The conference remains at the forefront of unraveling the mechanisms and improving the diagnosis and understanding of Alzheimer’s and other related neurodegenerative diseases. This year, the conference was hosted in Philadelphia, USA, from July 28th to August 1st, with the pre-conference which was held on July 27th (Alzheimer’s Imaging Corium). At this conference, attendees had the opportunity to review the basic, fundamental principles of amyloid and tau, Alzheimer’s Disease hallmarks, using fluids and PET biomarkers. Attending this conference allowed the students to learn more about neuroimaging and biomarkers, which are the key subjects of their thesis: discussing the pathogenesis of Alzheimer’s Disease, using plasma and PET-imaging biomarkers. They also shared their work at this international conference which would allow them to learn and exchange about their research in the field with other research groups.
HAI 2025 – HUMAN AMYLOID IMAGING
15-17 January 2025, San Juan, Puerto Rico
The students from the McGill Research Centre for Studies in Aging, attended the 2025 Human Amyloid Imaging (HAI-2025), which consisted of a ground-breaking series of talks on fluids and PET-biomarkers used in research on dementia. This conference remains at the forefront of unraveling the mechanisms and improving the diagnosis and understanding of Alzheimer’s and other related neurodegenerative diseases. The students had the opportunity to review the basic, fundamental principles of amyloid and tau, Alzheimer’s Disease hallmarks, using fluids and PET biomarkers. Attending this conference allowed the students to learn more about neuroimaging and biomarkers, which are the key subjects of their thesis: discussing the pathogenesis of Alzheimer’s Disease, using plasma and PET-imaging biomarkers. They presented the following posters and orals:
Dr. Arthur C. Macedo, MD | Poster: The spatial spread of tauopathy precedes the increase in tau-PET load in Alzheimer’s disease.” Poster: Head-to-head comparison of four tau-PET tracers for in vivo Braak staging: the HEAD Study |
Nesrine Rahmouni, PhD | Poster: Association between early and late tau aggregation across tau imaging agents: The HEAD Study Oral: PET astroglia and microglia follow tau propagation patterns in Alzheimer’s disease |
Brandon J. Hall, PhD | Poster & Mini-Oral: Cortical free water increases with tau tangle aggregation |
Gleb Bezgin | Poster: Comparison of distribution volume and standardized uptake value ratio for a MAO-B tracer in mild cognitive impairment |
Lydia Trudel, PhD | Poster: Patterns of tau-PET accumulation and clinical progression according to biological AD stages |
Honorary Presentation by Dr. Paolo Vitali “The role of biomarkers in the diagnosis of Alzheimer's Disease”
On February 7th, 2024, neurologist, Dr. Paolo Vitali, gave a talk on the role of biomarkers in the diagnosis of Alzheimer’s disease, for the Annule Colloquium Barclay Family Educational Series at the Alzheimer’s Society of Montreal.